Glutamatergic function in a genetic high-risk group for psychosis: A proton magnetic resonance spectroscopy study in individuals with 22q11.2 deletion. (2019)

First Author: Rogdaki M
Attributed to:  MICA: Targeting neuro-inflammation in Schizophrenia funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.euroneuro.2019.09.005

PubMed Identifier: 31648854

Publication URI: http://europepmc.org/abstract/MED/31648854

Type: Journal Article/Review

Volume: 29

Parent Publication: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Issue: 12

ISSN: 0924-977X